# Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke

> **NCT02956200** · PHASE2 · WITHDRAWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University**

## Conditions studied

- Stroke
- Inflammation

## Interventions

- **DRUG:** Fingolimod

## Key facts

- **NCT ID:** NCT02956200
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-07-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956200, "Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02956200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*